Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: a randomized controlled trial.
Published Feb 1, 2014 · S. Chuengsamarn, S. Rattanamongkolgul, B. Phonrat
The Journal of nutritional biochemistry
Q1 SJR score
266
Citations
22
Influential Citations
Abstract
Abstract removed due to Elsevier request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Study Snapshot
Key takeawayCurcumin supplementation for 6 months in type 2 diabetes patients significantly reduced atherogenic risks and improved metabolic profiles.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Sign up to use Study Snapshot
Consensus is limited without an account. Sign up or log in to use Study Snapshot and unlock more functionality.
···
···
···
···